D. E. Shaw & Co., Inc. Biotechnology

D. E. Shaw & Co., Inc.

  • $100 Billion
  • Q1 2025

Stock List

Stock Option Type Value Options Held Last Trade Trade History
MRNA
Moderna, Inc.
PUT
$95.7 Million
3.38M
Q1 2025
Added 218.66%
NVO
Novo Nordisk A S
PUT
$74.7 Million
1.08M
Q1 2025
Added 25.67%
ARGX
Argenx Se
CALL
$33.4 Million
56.4K
Q1 2025
Reduced 9.7%
REGN
Regeneron Pharmaceuticals, Inc.
CALL
$24.3 Million
38.3K
Q1 2025
Added 15.72%
REGN
Regeneron Pharmaceuticals, Inc.
PUT
$15 Million
23.6K
Q1 2025
Added 15.72%
MDGL
Madrigal Pharmaceuticals, Inc.
CALL
$7.42 Million
22.4K
Q1 2025
Added 315.22%
BNTX
Bio N Tech Se
PUT
$6.65 Million
73K
Q1 2025
Added 70.33%
MRNA
Moderna, Inc.
CALL
$6.64 Million
234K
Q1 2025
Added 218.66%
VRTX
Vertex Pharmaceuticals Inc
CALL
$6.21 Million
12.8K
Q1 2025
Reduced 72.93%
BNTX
Bio N Tech Se
CALL
$5.81 Million
63.8K
Q1 2025
Added 70.33%
ARGX
Argenx Se
PUT
$3.73 Million
6.3K
Q1 2025
Reduced 9.7%
BPMC
Blueprint Medicines Corp
CALL
$3.46 Million
39.1K
Q1 2025
Added 7.51%
NVO
Novo Nordisk A S
CALL
$3.19 Million
45.9K
Q1 2025
Added 25.67%
CYTK
Cytokinetics Inc
CALL
$2.92 Million
72.7K
Q1 2025
New holding
MDGL
Madrigal Pharmaceuticals, Inc.
PUT
$2.82 Million
8.5K
Q1 2025
Added 315.22%
TGTX
Tg Therapeutics, Inc.
CALL
$2.46 Million
62.5K
Q1 2025
Reduced 63.25%
CRSP
Crispr Therapeutics Ag
CALL
$1.75 Million
51.4K
Q3 2024
Added 4.23%
VRTX
Vertex Pharmaceuticals Inc
PUT
$1.07 Million
2.2K
Q1 2025
Reduced 72.93%
APLS
Apellis Pharmaceuticals, Inc.
PUT
$833,000
38.1K
Q4 2024
New holding
ASND
Ascendis Pharma A/S
CALL
$779,000
5K
Q1 2025
Reduced 45.96%
AXSM
Axsome Therapeutics, Inc.
CALL
$769,000
6.6K
Q1 2025
Added 2591.76%
INSM
Insmed Inc
PUT
$762,000
10K
Q1 2025
Added 44.44%
BPMC
Blueprint Medicines Corp
PUT
$584,000
6.6K
Q1 2025
Added 7.51%
VKTX
Viking Therapeutics, Inc.
CALL
$567,000
23.5K
Q1 2025
Added 219.14%
ALNY
Alnylam Pharmaceuticals, Inc.
CALL
$432,000
1.6K
Q1 2025
Reduced 20.17%
APLS
Apellis Pharmaceuticals, Inc.
CALL
$398,000
18.2K
Q4 2024
New holding
LEGN
Legend Biotech Corp
PUT
$308,000
9.1K
Q1 2024
Reduced 75.95%
ARWR
Arrowhead Pharmaceuticals, Inc.
PUT
$275,000
21.6K
Q4 2023
New holding
NTLA
Intellia Therapeutics, Inc.
PUT
$249,000
35.1K
Q1 2025
Reduced 3.53%
NVAX
Novavax Inc
CALL
$235,000
36.8K
Q1 2025
Reduced 43.68%
QURE
Uni Qure N.V.
CALL
$177,000
16.7K
Q4 2024
Reduced 59.68%
Filter Shares Options
Track This Portfolio

Track D. E. Shaw & Co., Inc. Portfolio

Follow D. E. Shaw & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email